Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by FullReversalon Oct 10, 2016 12:25pm
105 Views
Post# 25328209

The additional $72M USD finder's fee is on disclosures!

The additional $72M USD finder's fee is on disclosures!


Don't accuse me of making that up when it's in multiple OFFICIAL  filings! If you get off your butt and read the October and November 2015 filings you'll see it yourself instead of wasting your time here trying to fool fellow investors in following you into the worst stock to be long on!

What has not been disclosed by the company is whether or not this Amco/Cinven related "deal" a year ago was triggered by the four UK drug acquired this summer. The four drugs do fit the "profile" but the details around them is very sketchy as per Concordia's standard "mode of operation"!

Considering the poor disclosure practices of this company, they will likely release that "triggered bomb" during the next fiscal disclosures?

One month of pain as longs continue to slow bleed to death and BAM!  The final assault by management on shareholders in exaclty one month?!?!?

"Nov 10, 2016 Q3 2016 Concordia International Corp Earnings Release (Estimated) - 9:30AM EST"

I have learned an important lesson on CXR and the great short sellers here.  Watch
out for "non-gaap" and/or "adjusted EBITDA".  They make overvalued companies a target
for short sellers US Hedge Funds. 

CXR has transformed me from a classic buy and hold  long type of investor into one that
is now looking for short positions to balance out my porfolio.

Some of investors I chit chat to in real life are seeing the markets crash in our lifetimes,
and short selling has become a big area of discussion for us as a hedge against
portfolio devastation.

 
<< Previous
Bullboard Posts
Next >>